iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionEdge Wealth Management LLC
Latest Disclosed Ownership1,227 shares
Latest Disclosed Value $ 207,179
Edge Wealth Management LLC ownership in 0JGB / iShares Trust - iShares Biotechnology ETF

On April 20, 2026 - Edge Wealth Management LLC filed a 13F-HR form disclosing ownership of 1,227 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $207,179 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 1,227 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $160,798 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,227 0 0.00 207 0.00 0.0354
2026-01-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,227 1,227 207 0.0366
2023-04-18 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 0 -2,973 -100.00 0 -100.00
2023-01-25 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,973 2,973 386 0.0897
2022-10-18 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 0 -1,843 -100.00 0 -100.00
2022-07-22 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,843 1,843 217 0.0469
2022-04-14 2022-03-31 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 0 -294 -100.00 0 -100.00
2022-01-21 2021-12-31 13F/A-1 ISHARES BIOTECHNOLOGY ETF ETF 464287556 294 0 0.00 45 -6.25 0.0082
2022-01-14 2021-12-31 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 294 0 45 0.0082
2021-10-13 2021-09-30 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 294 -387 -56.83 48 -57.14 0.0094
2021-07-23 2021-06-30 13F ISHARES BIOTECHNOLOGY ETF ETF 464287556 681 0 0.00 112 8.74 0.0228
2021-04-09 2021-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF ETF 464287556 681 0 0.00 103 0.00 0.0219
2021-01-19 2020-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 681 -225 -24.83 103 -16.26 0.0234
2020-10-21 2020-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 906 -10,060 -91.74 123 -91.79 0.0283
2020-08-03 2020-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF ETF 464287556 10,966 -435 -3.82 1,499 22.07 0.2842
2020-04-20 2020-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 11,401 11,401 1,228 0.2666
2020-01-28 2019-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 0 -17,092 -100.00 0 -100.00
2019-10-21 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 17,092 -81,908 -82.74 1,700 -84.22 0.3914
2019-07-15 2019-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 99,000 48,704 96.83 10,771 91.38 2.3895
2019-04-11 2019-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 50,296 -725 -1.42 5,628 14.39 1.3867
2019-01-11 2018-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 51,021 36,559 252.79 4,920 178.91 1.3872
2018-10-22 2018-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 14,462 -235 -1.60 1,764 9.29 0.4237
2018-07-17 2018-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 14,697 -4,343 -22.81 1,614 -20.57 0.4106
2018-04-05 2018-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 19,040 17,768 1,396.86 2,032 1,394.12 0.5393
2018-01-17 2017-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 1,272 1,008 381.82 136 54.55 0.0385
2017-10-19 2017-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 264 0 0.00 88 6.02 0.0266
2017-08-02 2017-06-30 13F/A-1 ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 264 0 0.00 83 7.79 0.0261
2017-07-27 2017-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 264 0 83
2017-04-12 2017-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 264 -210 -44.30 77 -38.89 0.0267
2017-01-23 2016-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 474 374 374.00 126 334.48 0.0477
2016-10-12 2016-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 100 79 376.19 29 480.00 0.0123
2016-07-07 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY ETF 464287556 21 0 0.00 5 0.00 0.0021
2016-04-08 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY COM 464287556 21 0 0.00 5 -28.57 0.0023
2016-01-11 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY COM 464287556 21 20 2,000.00 7 600.00 0.0026
2015-10-07 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY COM 464287556 1 1 1 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.